🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn what dose of ruxolitinib can be...
Status
Recruiting
Location
University of California, San Diego Moores Cancer Center
Start Date
2026-01-08
Trial ID
NCT07219576
Treatments Being Tested
This study aims to determine whether morning versus afternoon treatment imp...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-12-02
Trial ID
NCT07224971
Treatments Being Tested
The purpose of this study is to evaluate the safety or treating pancreatic ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Start Date
2019-12-13
Trial ID
NCT04161755
Treatments Being Tested
The purpose of this study is to evaluate the safety of sequential intratumo...
Status
Completed
Location
Chevy Chase RCCA
Start Date
2015-03
Trial ID
NCT02423863
Treatments Being Tested
This retrospective real-world cohort study evaluated whether concomitant lo...
Status
Completed
Location
Department of Pharmacy, Affiliated Hospital of Nantong University
Start Date
2022-06-01
Trial ID
NCT05387512
Treatments Being Tested
A nonrandomized phase II trial is proposed combining avelumab (PD-L1 inhibi...
Status
Withdrawn
Location
AdventHealth Cancer Institute
Start Date
2023-05-08
Trial ID
NCT05574504
Treatments Being Tested
This is a phase 1, open-label study to evaluate the safety and tolerability...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-01
Trial ID
NCT06156267
Treatments Being Tested
Single arm, set dose clinical trial of Lamivudine for Relapsed Refractory S...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2024-09-26
Trial ID
NCT06494579
Treatments Being Tested